Literature DB >> 14076378

THE HAEMAGGLUTINATION INHIBITION AND THE HOGBEN TEST IN PREGNANCY.

J SHEA, A J WARRACK.   

Abstract

Haemagglutination inhibition tests are easy to perform and easy to read. The results are reproducible and are not subject to the vagaries of supply and temperament inherent in tests using living creatures. In a series of tests with Prepuerin done in parallel with the Hogben test the former has shown a higher sensitivity. There have been three false positive results with Prepuerin tests in the series but it was not established on general grounds that pregnancy was not in fact present.

Keywords:  CHORIOCARCINOMA; CHROMATOGRAPHY; EXPERIMENTAL LAB STUDY; HEMAGGLUTINATION INHIBITION TESTS; HYDATIDIFORM MOLE; NEOPLASM DIAGNOSIS; PREGNANCY; PREGNANCY TESTS; TESTICULAR NEOPLASMS

Mesh:

Substances:

Year:  1963        PMID: 14076378      PMCID: PMC480643          DOI: 10.1136/jcp.16.6.581

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  An immunological pregnancy test.

Authors:  L WIDE; C A GEMZELL
Journal:  Acta Endocrinol (Copenh)       Date:  1960-10

2.  Breeding of Xenopus laevis in captivity; evidence for the need to exchange tank water for tadpole husbandry on grounds of hygiene and mineral replacement.

Authors:  H SCHWABACHER; E ELKAN
Journal:  S Afr J Med Sci       Date:  1953-06

3.  Latex agglutination reactions between human chorionic gonadotropin and rabbit antibody.

Authors:  J L ROBBINS; G A HILL; B N CARLE; J H CARLQUIST; S MARCUS
Journal:  Proc Soc Exp Biol Med       Date:  1962-02

4.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

  4 in total
  1 in total

1.  A CRITICAL STUDY OF IMMUNOLOGICAL METHODS FOR PREGNANCY DIAGNOSIS.

Authors:  A J WORT; K N VARDE; D V FAIRWEATHER; C A GREEN
Journal:  J Clin Pathol       Date:  1963-11       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.